These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 26722033)

  • 1. Radiosensitivity of Prostate Cancer Cell Lines for Irradiation from Beta Particle-emitting Radionuclide ¹⁷⁷Lu Compared to Alpha Particles and Gamma Rays.
    Elgqvist J; Timmermand OV; Larsson E; Strand SE
    Anticancer Res; 2016 Jan; 36(1):103-9. PubMed ID: 26722033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer Cell Radiobiological Studies Using In-House-Developed α-Particle Irradiator.
    Nilsson J; Bauden MP; Nilsson JM; Strand SE; Elgqvist J
    Cancer Biother Radiopharm; 2015 Nov; 30(9):386-94. PubMed ID: 26560194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin-receptor-targeted alpha-emitting 213Bi is therapeutically more effective than beta(-)-emitting 177Lu in human pancreatic adenocarcinoma cells.
    Nayak TK; Norenberg JP; Anderson TL; Prossnitz ER; Stabin MG; Atcher RW
    Nucl Med Biol; 2007 Feb; 34(2):185-93. PubMed ID: 17307126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation Nanomedicine for EGFR-Positive Breast Cancer: Panitumumab-Modified Gold Nanoparticles Complexed to the β-Particle-Emitter, (177)Lu.
    Yook S; Cai Z; Lu Y; Winnik MA; Pignol JP; Reilly RM
    Mol Pharm; 2015 Nov; 12(11):3963-72. PubMed ID: 26402157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redefining relative biological effectiveness in the context of the EQDX formalism: implications for alpha-particle emitter therapy.
    Hobbs RF; Howell RW; Song H; Baechler S; Sgouros G
    Radiat Res; 2014 Jan; 181(1):90-8. PubMed ID: 24502376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential response of DU145 and PC3 prostate cancer cells to ionizing radiation: role of reactive oxygen species, GSH and Nrf2 in radiosensitivity.
    Jayakumar S; Kunwar A; Sandur SK; Pandey BN; Chaubey RC
    Biochim Biophys Acta; 2014 Jan; 1840(1):485-94. PubMed ID: 24121106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in the progression of cells through the cell cycle after exposure to alpha particles or gamma rays.
    Gadbois DM; Crissman HA; Nastasi A; Habbersett R; Wang SK; Chen D; Lehnert BE
    Radiat Res; 1996 Oct; 146(4):414-24. PubMed ID: 8927713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical efficacy of hK2 targeted [
    Timmermand OV; Elgqvist J; Beattie KA; Örbom A; Larsson E; Eriksson SE; Thorek DLJ; Beattie BJ; Tran TA; Ulmert D; Strand SE
    Theranostics; 2019; 9(8):2129-2142. PubMed ID: 31149033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha- versus beta-particle radiopeptide therapy in a human prostate cancer model (213Bi-DOTA-PESIN and 213Bi-AMBA versus 177Lu-DOTA-PESIN).
    Wild D; Frischknecht M; Zhang H; Morgenstern A; Bruchertseifer F; Boisclair J; Provencher-Bolliger A; Reubi JC; Maecke HR
    Cancer Res; 2011 Feb; 71(3):1009-18. PubMed ID: 21245097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling Cell and Tumor-Metastasis Dosimetry with the Particle and Heavy Ion Transport Code System (PHITS) Software for Targeted Alpha-Particle Radionuclide Therapy.
    Lee D; Li M; Bednarz B; Schultz MK
    Radiat Res; 2018 Sep; 190(3):236-247. PubMed ID: 29944461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility of the human pathogenic fungi Cryptococcus neoformans and Histoplasma capsulatum to gamma-radiation versus radioimmunotherapy with alpha- and beta-emitting radioisotopes.
    Dadachova E; Howell RW; Bryan RA; Frenkel A; Nosanchuk JD; Casadevall A
    J Nucl Med; 2004 Feb; 45(2):313-20. PubMed ID: 14960655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the alpha-particle emitter At-211 and low-dose-rate gamma-radiation on the human cell line Colo-205 as studied with a growth assay.
    Palm S; Bäck T; Claesson I; Delle U; Hultborn R; Jacobsson L; Köpf I; Lindegren S
    Anticancer Res; 1998; 18(3A):1671-6. PubMed ID: 9673388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenoviral-mediated p53 transgene expression sensitizes both wild-type and null p53 prostate cancer cells in vitro to radiation.
    Colletier PJ; Ashoori F; Cowen D; Meyn RE; Tofilon P; Meistrich ME; Pollack A
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1507-12. PubMed ID: 11121656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative biological effectiveness of high linear energy transfer α-particles for the induction of DNA-double-strand breaks, chromosome aberrations and reproductive cell death in SW-1573 lung tumour cells.
    Franken NA; Hovingh S; Ten Cate R; Krawczyk P; Stap J; Hoebe R; Aten J; Barendsen GW
    Oncol Rep; 2012 Mar; 27(3):769-74. PubMed ID: 22200791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical alterations in human cells irradiated with alpha particles delivered by macro- or microbeams.
    Gault N; Rigaud O; Poncy JL; Lefaix JL
    Radiat Res; 2007 May; 167(5):551-62. PubMed ID: 17474787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of chronic hypoxic cells to low dose-rate irradiation.
    Pettersen EO; Bjørhovde I; Søvik A; Edin NF; Zachar V; Hole EO; Sandvik JA; Ebbesen P
    Int J Radiat Biol; 2007 May; 83(5):331-45. PubMed ID: 17457758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiosensitivity of colorectal cancer to
    Lee BQ; Abbott EM; Able S; Thompson JM; Hill MA; Kartsonaki C; Vallis KA; Falzone N
    Phys Med Biol; 2019 Jul; 64(13):135018. PubMed ID: 31117062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrovascular diseases incidence and mortality in an extended Mayak Worker Cohort 1948-1982.
    Azizova TV; Haylock RG; Moseeva MB; Bannikova MV; Grigoryeva ES
    Radiat Res; 2014 Nov; 182(5):529-44. PubMed ID: 25361397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of in vitro and in vivo alpha/beta ratios for prostate cancer.
    Carlson DJ; Stewart RD; Li XA; Jennings K; Wang JZ; Guerrero M
    Phys Med Biol; 2004 Oct; 49(19):4477-91. PubMed ID: 15552412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the high-dose-range radioresistance of prostate cancer cells, including cancer stem cells, based on a stochastic model.
    Saga R; Matsuya Y; Takahashi R; Hasegawa K; Date H; Hosokawa Y
    J Radiat Res; 2019 May; 60(3):298-307. PubMed ID: 31034058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.